Wet age-related macular degeneration (AMD) treatment using intravitreal ranibizumab needs to be started as soon as possible and treatment must be administered based on regular review to achieve the best results. In clinical practice this tight schedule is a challenge and methods of carrying out such timely treatment is the objective of this quality improvement work. A departmental audit was carried out on the service providing treatment for patients with wet AMD in 2009. This audit identified that the appointment system did not meet the ideal standards and subsequently wet AMD patients' visual outcome were poorer than the standard set in trials where the patients were seen and treated at predetermined intervals. In order to enhance the visual benefit of the administered therapy for our patients we thought it necessary to find ways to see and treat patients sooner as well as reduce time intervals between follow-up appointments. The quality improvement was carried out through redesigning the service in the macular treatment centre of Manchester Royal Eye Hospital. Three main strategies were implemented including: changes to the appointment system, expansion of the treatment facility and employment of additional staff. Following changes made, regular re-audits were used to analyse the effectiveness of the new strategies. The changes introduced have brought appointment standards to the level of Royal College of Ophthalmologists' recommendations. Consequently visual outcomes were approaching the standards set by landmark studies. The visual improvement of treated patients seen in the 2011 audit are comparable to other reports outside clinical trials in the UK. In order to enhance the efficacy of ranibizumab for wet AMD it is essential for treatment to be initiated as soon as possible and administered to patients at the recommended time intervals. The actions we have taken were effective in helping develop a service performing to higher standards.
Problem
Age-related macular degeneration (AMD) is the most common cause of visual impairment in adults over the age of 50 in the developed world. This condition is a major health concern with over 250,000 adults in the United Kingdom suffering from blindness due to AMD. Ophthalmologists is particularly challenging. In the largest cohort study to date investigating compliance to these standards in France, not one patient (of 551 patients followed by 16 ophthalmologists) adhered to the treatment schedule entirely. (4) These guidelines recommend ranibizumab treatment be started within 2 weeks from referral to the eye unit and within 1 week from the first hospital visit. (5) In what is referred to as the loading phase of treatment, the first 3 injections must be given at monthly intervals. Further ranibizumab injections need to be administered as indicated guided by regular monthly reviews in the maintenance 
Strategy
In order to see greater improvement in the mean visual acuity of patients with wet AMD we continuously aimed to find ways to see and treat patients according to the guidelines. The visual improvement can be demonstrated by higher number of patients gaining significant vision as a result of their therapy as well as fewer patients losing significant vision.
All of these changes not only directly increased treating capacity, but they allowed stronger teams to form in a better organized environment that contributed to better staff morale and work satisfaction which also resulted in better patient satisfaction.
See supplementary file: ds1904.docx -"Results"
Lessons and Limitations
Results show changes that were made to the service provided at the MTC resulted in improved visual acuity. These changes aimed to reduce the time interval between appointments to reach targets set by the Royal College of Ophthalmologists.
Our study showed that complying with the recommended time 
Conclusion
Our study showed that complying with the recommended time Virtual clinics were set-up whereby patients attend an assessment appointment and only those come for injection whose results reviewed by an assessing ophthalmologist indicate the necessity of treatment. This increases capacity as the assessment sessions don't need to be staffed by doctors and a higher volume of patients can be reviewed per session by a doctor. This concept seems to be improving follow-up times as consultants are able to go through many patient assessments quickly in one session and identify those patients that need to come in again for treatment. Electronic patient records implementation is expected to reduce appointment time increasing capacity further by making documentation and review of history quicker allowing more time to spend with direct patient care in clinic.
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